TRUNA
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Truscreen Group Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Truscreen Group Limited - Ordinary Fully Paid Deferred
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in TRUNA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in TRUNA
N/A
TRUNA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in TRUNA also invest in...
Want more shares? Try these...
TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. The firm is engaged in the business of the development, manufacture and sale of cancer detection devices and systems. The firm offers AI-enabled device, namely TruScreen a cervical cancer screening device that detects precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. TruScreen uses, opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable single use sensor, a handheld device (HHD), and an intelligent cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. The product offers an approach to cervical screening, resolving ongoing issues with Pap smear (Pap tests), including failed samples, patient follow-up and discomfort, and the need for supporting laboratory infrastructure, as well as problems associated with human papillomavirus (HPV) tests.